Sphingolipids in Alzheimer's disease, how can we target them?
- Simone M Crivelli
- , Caterina Giovagnoni
- , Lars Visseren
- , Anna-Lena Scheithauer
- , Nienke de Wit
- , Sandra den Hoedt
- , Mario Losen
- , Monique T Mulder
- , Jochen Walter
- , Helga E de Vries
- , Erhard Bieberich
- , Pilar Martinez-Martinez
- Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, Netherlands; Department of Clinical Epidemiology and Medical Technology Assessment, School for Public Health and Primary Care, Maastricht University, Maastricht, Netherlands; Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, Netherlands.
- Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
- Department of General Practice, Erasmus MC, University Medical Center Rotterdam, The Netherlands; Department of Orthopedics, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
- University of Kentucky College of Medicine
Research output: Contribution to journal › Review article › Academic › peer-review